// App-Quantinova.ai

: SVT discrimination algorithms significantly reduce the rates of inappropriate therapies in the setting of modern day delayed high-rate detection programming

Researchers

Presenter

  • A. Cheng

Principal Investigators

  • A. Auricchio

  • E.J. Schloss

  • L.D. Sterns

  • B.E.W. Gerritse

  • T. Kurita

  • A. Meijer

  • M. Brown

  • K. Ellenbogen

Medical Centers

  • Medtronic Inc - Minneapolis - United States of America

  • Cardiocentro Ticino, Lugano, Switzerland

  • The Christ Hospital, Cincinnati, United States of America

  • Royal Jubilee Hospital, Victoria, BC

  • Medtronic Bakken Research Center, Maastricht, Netherlands

  • Kinki University, Osaka, Japan

  • Catharina hospital, Eindhoven, Netherlands

  • Virginia Commonwealth University, VA, United States

Locations

  • Switzerland

  • Canada

  • Netherlands

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Somatostatin

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved